Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a ...

NVIDIA Co. (NASDAQ: NVDA) is the undisputed leader of the artificial intelligence (AI) revolution. The company envisioned an ...

Artificial intelligence (AI) is revolutionizing pharmaceutical R&D, helping to accelerate drug development, improve operational efficiencies and diagnostics whilst reducing associated costs. Drug ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

The next administration must recognize that getting ahead in the AI race will both protect U.S. national security and stem ...

Proponents of the technology say it has the potential to make drug discovery faster and cheaper. In 2025 it may begin ...

Neural networks propel AI revolution. The Nobel Prize in physics was awarded to Geoffrey Hinton, often referred to as the ...

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...

Living Cell Technologies Ltd. (AU:1AI) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...

Palantir is profitable, so we can consider its forward price-to-earnings ratio -- and right now the stock trades for more ...